A Phase 2 Study of Lenalidomide, Rituximab, Cyclophosphamide and Dexamethasone (LR-CD) for Untreated Low Grade Non-Hodgkin Lymphoma Requiring Therapy
Titel:
A Phase 2 Study of Lenalidomide, Rituximab, Cyclophosphamide and Dexamethasone (LR-CD) for Untreated Low Grade Non-Hodgkin Lymphoma Requiring Therapy
Auteur:
Rosenthal, Allison Dueck, Amylou C. Ansell, Stephen M. Gano, Katherine Conley, Christopher Nowakowski, Grzegorz S. Curtis, Kelly Camoriano, John Leis, Jose F. Slack, James Valdez, Riccardo Mikhael, Joseph R. Stewart, A. Keith Inwards, David Dingli, David Kumar, Shaji Noel, Pierre Gertz, Morie Porrata, Luis Russell, Stephen Colgan, Joseph Fonseca, Rafael Habermann, Thomas M. Kapoor, Prashant Buadi, Francis Leung, Nelson Tiedemann, Rodger Witzig, Thomas E. Reeder, Craig